[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643615":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":25,"responsibleParty":45,"collaborators":47,"id":51,"slug":18,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":18,"maxAge":18,"enrollmentInfo":59,"targetDuration":18,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":71,"overallStatus":28,"whyStopped":18,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"CareAcross","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1 - Experimental","EXPERIMENTAL","Participants in this group utilize the personalized digital platform to record adverse events as Patient-Reported Outcomes (PROs). Additionally, they receive short textual personalized educational and supportive material online.\n\nTheir standard clinical treatment and monitoring continue unaffected.",[13],"Behavioral: Digital support",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm 2 - Control","NO_INTERVENTION","Participants in this group utilize the personalized digital platform to record adverse events as Patient-Reported Outcomes (PROs). They only receive an acknowledgement of their submission.\n\nTheir standard clinical treatment and monitoring continue unaffected.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Digital support","Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.",[9],[26],{"facility":27,"status":28,"city":29,"state":18,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Alexandra General Hospital","RECRUITING","Athens","11528","Greece","GR",{"type":34,"coordinates":35},"Point",[36,37],23.72784,37.98376,{"lat":37,"lon":36},[40],{"name":41,"role":42,"phone":43,"phoneExt":18,"email":44},"Professor Evangelos Terpos","CONTACT","+302132162846","eterpos@med.uoa.gr",{"type":46,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[48],{"name":49,"class":50},"Μedical Association for the Study of Cancer Biology and Treatments (Μ.Α.S.CA.B.T.)","UNKNOWN","100643615",false,"NCT07642362","Digital Support for Multiple Myeloma Quality of Life","Digital Support for Enhancing the Quality of Life of Patients With Multiple Myeloma: An Observational, Randomized, Prospective Study (DigiMyQoL)","DigiMyQoL","Inclusion Criteria:\n\n* Adult patients with newly diagnosed or relapsed\u002Frefractory multiple myeloma\n* Patients that are able to use the digital platform\u002Fapplication\n\nExclusion Criteria:\n\n* Patients that are not able to use the digital platform\u002Fapplication","ALL",{"count":60,"type":61},108,"ESTIMATED","INTERVENTIONAL",[64],"NA","The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform.\n\nSpecifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.",[67,68,69,70],"Multiple Myeloma","Patient Reported Outcome (PRO)","Supportive Care in Cancer","Quality of Life",[72,73,74,75,76,77,78],"multiple myeloma","quality of life","qol","patient reported outcome","pro","digital oncology","supportive care","2026-06-07",{"date":81,"type":82},"2026-06-11","ACTUAL",{"date":84,"type":82},"2025-02-27",{"date":86,"type":61},"2028-03",{"name":5,"class":6},1]